COVID-19 SARS-CoV-2 preprints from medRxiv and bioRxiv

31,137 Articles (22,693 medRxiv, 8,444 bioRxiv)

Most recent first Previous |  Page 2358: Articles 23571-23580  | Next

A "Tail" of Two Cities: Fatality-based Modeling of COVID-19 Evolution in New York City and Cook County, IL
Frieman, J.
10.1101/2020.08.10.20170506 — Posted: 2020-08-12
The Build-Up of Droplet/Aerosols Carrying the SARS-CoV-2 Coronavirus, in Confined Spaces
Birnir, B., Angheluta, L.
10.1101/2020.08.11.20173195 — Posted: 2020-08-12
The impact of non-pharmaceutical interventions on SARS-CoV-2 transmission across 130 countries and territories
Liu, Y., Morgenstern, C., Kelly, J., Lowe, R., CMMID COVID-19 Working Group, , Jit, M.
10.1101/2020.08.11.20172643 — Posted: 2020-08-12 Discussion: Offsite
Rapid endothelialitis and vascular inflammation characterise SARS-CoV-2 infection in a human lung-on-chip model
Thacker, V. V., Sharma, K., Dhar, N., Mancini, G.-F., Sordet-Dessimoz, J., Mckinney, J. D.
10.1101/2020.08.10.243220 — Posted: 2020-08-12
Development of CpG-adjuvanted stable prefusion SARS-CoV-2 spike antigen as a subunit vaccine against COVID-19
Kuo, T.-Y., Lin, M.-Y., Coffman, R. L., Campbell, J. D., Traquina, P., Lin, Y.-J., Liu, L. T. C., Cheng, J., Wu, Y.-C., Wu, C.-C., Tang, W.-H., Huang, C.-G., Tsao, K.-C., Shih, S.-R., Chen, C.
10.1101/2020.08.11.245704 — Posted: 2020-08-11
Opposing activities of IFITM proteins in SARS-CoV-2 infection
Shi, G., Kenney, A. D., Kudryashova, E., Zhang, L., Hall-Stoodley, L., Robinson, R., Kudryashov, D., Compton, A. A. S., Yount, J. S.
10.1101/2020.08.11.246678 — Posted: 2020-08-11
Common low complexity regions for SARS-CoV-2 and human proteomes as potential multidirectional risk factor in vaccine development
Gruca, A., Ziemska-Legiecka, J., Jarnot, P., Sarnowska, E., Sarnowski, T., Grynberg, M.
10.1101/2020.08.11.245993 — Posted: 2020-08-11
K18-hACE2 mice develop respiratory disease resembling severe COVID-19
Yinda, C. K., Port, J. R., Bushmaker, T. J., Offei Owusu, I., Avanzato, V. A., Fischer, R. J., Schulz, J. E., Holbrook, M. G., Hebner, M. J., Rosenke, R., Thomas, T., Marzi, A., Best, S. M., de Wit, E., Shaia, C., van Doremalen, N., Munster, V.
10.1101/2020.08.11.246314 — Posted: 2020-08-11
Ambroxol and Ciprofloxacin Show Activity Against SARS-CoV2 in Vero E6 Cells at Clinically-Relevant Concentrations
Timmins, G. S., Bradfute, S. B., Deretic, V., Kumar, S., Clarke, E. C., Ye, C.
10.1101/2020.08.11.245100 — Posted: 2020-08-11
Pleiotropic effect of Lactoferrin in the prevention and treatment of COVID-19 infection: in vivo, in silico and in vitro preliminary evidences
Campione, E., Lanna, C., Cosio, T., Rosa, L., Conte, M. P., Iacovelli, F., Romeo, A., Falconi, M., Del Vecchio, C., Franchin, E., Lia, M. S., Minieri, M., Chiaramonte, C., Ciotti, M., Nuccetelli, M., Terrinoni, A., Iannuzzi, I., Coppeda, L., Magrini, A., Moricca, N., Sabatini, S., Rosapepe, F., Bartoletti, P. L., Bernardini, S., Andreoni, M., Valenti, P., Bianchi, L.
10.1101/2020.08.11.244996 — Posted: 2020-08-11 Discussion: Onsite | Offsite

RSS  Collection RSS | JSON

The feeds linked above output metadata for the 100 most recent papers in the collection.To access the metadata for the entire collection in JSON or XML, visit the collection API.

Subject Areas
* The Clinical Trials and Epidemiology subject categories are now closed to new submissions following the completion of bioRxiv's clinical research pilot project and launch of the dedicated health sciences server medRxiv (submit.medrxiv.org). New papers that report results of Clinical Trials must now be submitted to medRxiv. Most new Epidemiology papers also should be submitted to medRxiv, but if a paper contains no health-related information, authors may choose to submit it to another bioRxiv subject category (e.g., Genetics or Microbiology).